ArticleJournal of cancer research and clinical oncology2023

Survival outcomes from atezolizumab plus bevacizumab versus Lenvatinib in Child Pugh B unresectable hepatocellular carcinoma patients.

Margherita Rimini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.